Funder
Peking University First Hospital
Reference28 articles.
1. FDA approves tofacitinib for rheumatoid arthritis;Traynor;Am J Health Syst Pharm,2012
2. Tofacitinib or adalimumab versus placebo in rheumatoid arthritis;van Vollenhoven;N Engl J Med,2012
3. Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial;Burmester;Lancet,2013
4. Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial;Fleischmann;Lancet,2017
5. Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis;Fleischmann;N Engl J Med,2012
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献